Dr. Lidia Schapira, MD

Dr. Schapira practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Schapira's NPI, 1669463709, was assigned on October 28, 2005. Dr. Schapira graduated from Geisel School Of Medicine At Dartmouth in 1982. Dr. Schapira holds California license G146222.

Dr. Schapira's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Schapira's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Schapira to 1 more hospital, named with a free account. Dr. Schapira's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schapira practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Schapira's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Schapira is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Schapira's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists breast cancer and lung cancer among the conditions Dr. Schapira treats.

CMS data shows 140 Medicare services from Dr. Schapira across 4 procedure codes in 2024, for 126 Medicare patients. Medicare paid $14,165 for them.

CMS counts 126 Medicare patients who saw Dr. Schapira in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have cancer, and 72% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schapira's median patient age at 58, with 96% women.

In 2024, Dr. Schapira wrote 127 Medicare Part D claims for 40 patients. 87% of them were for generic drugs. CMS names the drug for 116 of them, across 5 drugs with 11 or more claims each, at $194,949 in total drug cost. In 2023, CMS named 165 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Schapira for performance year 2024, reported as part of a group. Dr. Schapira accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schapira as offering telehealth.

Dmand AI links 160 papers to Dr. Schapira, published from 2005 to 2025. 2022 was the busiest year, with 17. The most frequent topics are Breast Neoplasms, Cancer Survivors and Survivors. Dr. Schapira has published most often in Cancer. Dr. Schapira's most frequent co-authors are Kathryn Jean Ruddy, MD, MPH, Virginia F. Borges, MD and Ann H. Partridge, MD, MPH.

CMS Open Payments shows 6 general payments to Dr. Schapira from 4 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 83% of the total. Pfizer Inc. paid the most, $3,700.

Dr. Schapira graduated from Geisel School Of Medicine At Dartmouth in 1982.

Dr. Schapira is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and Elevance. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.